BeiGene Ltd (HK:6160) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BeiGene Ltd., a biopharmaceutical company, has released its quarterly report for the period ending September 30, 2024. The company, listed on both the Nasdaq and Hong Kong exchanges, reported that it has filed all required reports and is not classified as a shell company. With over 1.3 billion ordinary shares outstanding, BeiGene continues to operate actively in global markets.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.